|
NCAPD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.698800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.953900E-02 |
| Normal-vs-Stage2 |
7.577600E-01 |
| Normal-vs-Stage3 |
1.418770E-01 |
| Normal-vs-Stage4 |
6.297400E-03 |
| Stage1-vs-Stage2 |
3.595600E-01 |
| Stage1-vs-Stage3 |
5.509400E-01 |
| Stage1-vs-Stage4 |
1.978400E-02 |
| Stage2-vs-Stage3 |
2.774200E-01 |
| Stage2-vs-Stage4 |
1.109570E-02 |
| Stage3-vs-Stage4 |
5.678300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.660200E-03 |
| Normal-vs-AfricanAmerican |
7.255200E-01 |
| Normal-vs-Asian |
1.479360E-01 |
| Caucasian-vs-AfricanAmerican |
1.262190E-01 |
| Caucasian-vs-Asian |
1.572370E-01 |
| AfricanAmerican-vs-Asian |
1.715170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.580400E-03 |
| Normal-vs-Female |
7.032100E-02 |
| Male-vs-Female |
2.043000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.545500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.160160E-02 |
| Normal-vs-Age(61-80Yrs) |
2.966300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.634100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.006800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.236800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.687680E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.432600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.860310E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.043300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.572200E-01 |
| Normal-vs-Grade 2 |
1.279430E-01 |
| Normal-vs-Grade 3 |
8.429800E-02 |
| Normal-vs-Grade 4 |
7.197600E-03 |
| Grade 1-vs-Grade 2 |
9.844400E-01 |
| Grade 1-vs-Grade 3 |
7.139200E-01 |
| Grade 1-vs-Grade 4 |
2.835700E-02 |
| Grade 2-vs-Grade 3 |
5.530000E-01 |
| Grade 2-vs-Grade 4 |
1.911900E-02 |
| Grade 3-vs-Grade 4 |
3.237700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.736400E-01 |
| Normal-vs-ccB subtype |
1.677540E-03 |
| ccA subtype-vs-ccB subtype |
1.318380E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.677500E-02 |
| Normal-vs-N1 |
1.483790E-02 |
| N0-vs-N1 |
4.350000E-02 |
|
|
